Benzinga's Top Initiations - Agile Therapeutics (OTC:AGRX), Kura Oncology (NASDAQ:KURA)

Analysts at Oppenheimer initiated coverage on

Kura Oncology Inc KURA

with a Outperform rating. The target price for Kura Oncology is set to $16. Kura Oncology shares closed at $7.01 on Tuesday. Analysts at Wells Fargo initiated coverage of

Avangrid, Inc.AGR

with a Outperform rating. Avangrid shares closed at $37.67 on Tuesday. Analysts at Oppenheimer initiated coverage on

Skullcandy Inc SKUL

with a Outperform rating. Skullcandy shares closed at $4.78 on Tuesday. Analysts at Noble Financial initiated coverage on

Agile Therapeutics Inc AGRX

with a Buy rating. The target price for Agile Therapeutics is set to $16. Agile Therapeutics shares closed at $8.91 on Tuesday. Oppenheimer initiated coverage on

Performance Sports Group Ltd PSG

with a Outperform rating. Performance Sports Group shares closed at $9.72 on Tuesday.

Market News and Data brought to you by Benzinga APIs